sclareol has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, B; Duan, G; Hou, S; Ji, J | 1 |
| Han, H; He, HS; He, N; Liu, ZG; Wang, L; Wang, ZY; Xiong, M; Xu, SJ; Yu, HL; Zeng, Y | 1 |
2 other study(ies) available for sclareol and Osteogenic Sarcoma
| Article | Year |
|---|---|
The study of sclareol in inhibiting proliferation of osteosarcoma cells by apoptotic induction and loss of mitochondrial membrane potential.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes; Dose-Response Relationship, Drug; Humans; Membrane Potential, Mitochondrial; Osteosarcoma | 2018 |
Sclareol, a plant diterpene, exhibits potent antiproliferative effects via the induction of apoptosis and mitochondrial membrane potential loss in osteosarcoma cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; G1 Phase Cell Cycle Checkpoints; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Osteosarcoma | 2015 |